Stanford professor Russ Altman acknowledges that startups often fear regulators, but insists that in the biotech space, the FDA is keen to work with companies to bring products to market and advise startups as part of an open dialogue. In the context of AI-driven drug development, GSK senior VP and Global Head of AI/ML Kim Branson adds, an evolving conversation between industry and government will lead to new ways of ensuring the safe delivery of cutting-edge therapies.
Related
Alexandra Zatarain,
Eight Sleep
Getting to Product-Market Fit [Entire Talk]
Product-market fit is a journey. Knowing your audience and mission will help you on your way.
Alexandra Zatarain,
Eight Sleep
Getting to Product-Market Fit [Entire Talk]
Product-market fit is a journey. Knowing your audience and mission will help you on your way.
Maria Barrera,
Clayful
Mental Health Tech, Mentally Healthy Startups [Entire Talk]
Startups can address important mental health problems, but maintaining mental health in startup culture is challenging.
Maria Barrera,
Clayful
Mental Health Tech, Mentally Healthy Startups [Entire Talk]
Startups can address important mental health problems, but maintaining mental health in startup culture is challenging.
David Allemann,
On
Exploration in Sports Technology [Entire Talk]
Taking a risk on an innovative idea can be the spark of a global company.
David Allemann,
On
Exploration in Sports Technology [Entire Talk]
Taking a risk on an innovative idea can be the spark of a global company.
